Family planning for obese women: Challenges and opportunities

Contraception

Volumn 72, Issue 1, 2005, Pages 1-4

  Grimes, David A ^a,b   Shields, Wayne C ^c  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Association of Reproductive Health Professionals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MISOPROSTOL; ORAL CONTRACEPTIVE AGENT; OXYTOCIN; PROSTAGLANDIN;

ABORTION; BODY MASS; CANCER RISK; CHILDBIRTH; CONTRACEPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; EDITORIAL; FAMILY PLANNING; FEMALE; FEMALE STERILIZATION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; OBESITY; PREGNANCY; PREGNANCY RATE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TRANSDERMAL PATCH; TREATMENT FAILURE; UTERUS RUPTURE; VENOUS THROMBOEMBOLISM;

ABORTION, INDUCED; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL; FAMILY PLANNING SERVICES; FEMALE; HUMANS; INTRAUTERINE DEVICES; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY, UNPLANNED; STERILIZATION, TUBAL;

EID: 20444450920     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2005.04.002     Document Type: Editorial

References (51)

1. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect 1998;30:24-9, 46.
2. National Center for Health Statistics Prevalence of overweight and obesity among adults: United States, 1999-2002 2005 http://www.cdc.gov/nchs/ products/pubs/pubd/hestats/obese/obse99.htm#Table%201 [accessed February 9, 2005]
3. L.T. Strauss, J. Herndon, and J. Chang Abortion surveillance - United States, 2001 MMWR Surveill Summ 53 2004 1 32
4. J.K. Lake, C. Power, and T.J. Cole Women's reproductive health: the role of body mass index in early and adult life Int J Obes Relat Metab Disord 21 1997 432 438
5. M. Vessey Oral contraceptive failures and body weight: findings in a large cohort study J Fam Plann Reprod Health Care 27 2001 90 91
6. V.L. Holt, K.L. Cushing-Haugen, and J.R. Daling Body weight and risk of oral contraceptive failure Obstet Gynecol 99 2002 820 827
7. V.L. Holt, D. Scholes, K.G. Wicklund, K.L. Cushing-Haugen, and J.R. Daling Body mass index, weight, and oral contraceptive failure risk Obstet Gynecol 105 2005 46 52
8. R. Speerhas Drug metabolism in malnutrition and obesity: clinical concerns Cleve Clin J Med 62 1995 73 75
9. F.A. Anderson Jr., H.B. Wheeler, R.J. Goldberg, D.W. Hosmer, and A. Forcier The prevalence of risk factors for venous thromboembolism among hospital patients Arch Intern Med 152 1992 1660 1664
10. H. Blaszyk, P.C. Wollan, A.K. Witkiewicz, and J. Bjornsson Death from pulmonary thromboembolism in severe obesity: lack of association with established genetic and clinical risk factors Virchows Arch 434 1999 529 532
11. M.M. Samama An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study Arch Intern Med 160 2000 3415 3420
12. V. Kim, and J. Spandorfer Epidemiology of venous thromboembolic disease Emerg Med Clin North Am 19 2001 839 859
13. A.L. Nightingale, R.A. Lawrenson, E.L. Simpson, T.J. Williams, K.D. MacRae, and R.D. Farmer The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives Eur J Contracept Reprod Health Care 5 2000 265 274
14. S. Gu, I. Sivin, and M. Du Effectiveness of Norplant implants through seven years: a large-scale study in China Contraception 52 1995 99 103
15. G.S. Grubb, D. Moore, and N.G. Anderson Pre-introductory clinical trials of Norplant implants: a comparison of seventeen countries' experience Contraception 52 1995 287 296
16. I. Sivin, L. Wan, and S. Ranta Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants Contraception 64 2001 43 49
17. M. Zieman, J. Guillebaud, E. Weisberg, G.A. Shangold, A.C. Fisher, and G.W. Creasy Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data Fertil Steril 77 2002 S13 S18
18. World Health Organization Medical eligibility criteria for contraceptive use, third edition 2005 http://www.who.int/reproductive-health/publications/ MEC_3/index.htm [accessed February 11, 2005]
19. M. Paul E.S. Lichtenberg L. Borgatta D.A. Grimes P.G. Stubblefield A clinician's guide to medical and surgical abortion 1999 Churchill Livingstone New York 175 176
20. A.C. Dark, L. Miller, R.L. Kothenbeutel, and L. Mandel Obesity and second-trimester abortion by dilation and evacuation J Reprod Med 47 2002 226 230
21. D.A. Marchiano, A.G. Thomas, R. Lapinski, K. Balwan, and J. Patel Intraoperative blood loss and gestational age at pregnancy termination Prim Care Update Obstet Gynecol 5 1998 204 205
22. A.M. Kimball, A.V. Hallum, and W. Cates Jr. Deaths caused by pulmonary thromboembolism after legally induced abortion Am J Obstet Gynecol 132 1978 169 174
23. J.L. Carbonell, J. Rodriguez, and E. Delgado Vaginal misoprostol 800 microg every 12 h for second-trimester abortion Contraception 70 2004 55 60
24. J.L. Carbonell, L. Varela, A. Velazco, R. Tanda, and C. Sanchez Vaginal misoprostol for abortion at 10-13 weeks' gestation Eur J Contracept Reprod Health Care 4 1999 35 40
25. L. Berghahn, D. Christensen, and S. Droste Uterine rupture during second-trimester abortion associated with misoprostol Obstet Gynecol 98 2001 976 977
26. A.L. Petri Uterine rupture during second trimester abortion induced with misoprostol Ugeskr Laeger 165 2003 2894 2895
27. J.E. Dickinson Misoprostol for second-trimester pregnancy termination in women with a prior cesarean delivery Obstet Gynecol 105 2005 352 356
28. G.J. Daskalakis, S.A. Mesogitis, N.E. Papantoniou, G.G. Moulopoulos, A.A. Papapanagiotou, and A.J. Antsaklis Misoprostol for second trimester pregnancy termination in women with prior caesarean section Br J Obstet Gynaecol 112 2005 97 99
29. 2 versus concentrated oxytocin Am J Obstet Gynecol 167 1992 1112 1116
30. I.C. Chi, L.E. Laufe, S.D. Gardner, and M.A. Tolbert An epidemiologic study of risk factors associated with pregnancy following female sterilization Am J Obstet Gynecol 136 1980 768 773
31. I.C. Chi, and L. Wilkens Interval tubal sterilization in obese women - an assessment of risks Am J Obstet Gynecol 152 1985 292 297
32. D.J. Jamieson, S.D. Hillis, A. Duerr, P.A. Marchbanks, C. Costello, and H.B. Peterson Complications of interval laparoscopic tubal sterilization: findings from the United States Collaborative Review of Sterilization Obstet Gynecol 96 2000 997 1002
33. I.C. Chi, L.R. Wilkens, and S.E. Reid Prolonged hospital stay after laparoscopic sterilization IPPF Med Bull 18 1984 3 4
34. H.B. Peterson, J.F. Hulka, F.J. Spielman, S. Lee, and P.A. Marchbanks Local versus general anesthesia for laparoscopic sterilization: a randomized study Obstet Gynecol 70 1987 903 908
35. A.N. Poindexter, M. Ritter, A. Fahim, and H. Humphrey Trocar introduction performed during laparoscopy of the obese patient Surg Gynecol Obstet 165 1987 57 59
36. K.B. Singh, H.T. Huddleston, and I. Nandy Laparoscopic tubal sterilization in obese women: experience from a teaching institution South Med J 89 1996 56 59
37. I. Chi, S.D. Mumford, and L.E. Laufe Technical failures in tubal ring sterilization: incidence, perceived reasons, outcome, and risk factors Am J Obstet Gynecol 138 1980 307 312
38. D.K. Rose, and M.M. Cohen The airway: problems and predictions in 18,500 patients Can J Anaesth 41 1994 372 383
39. K.R. Andreasen, M.L. Andersen, and A.L. Schantz Obesity and pregnancy Acta Obstet Gynecol Scand 83 2004 1022 1029
40. L. Rode, L. Nilas, K. Wojdemann, and A. Tabor Obesity-related complications in Danish single cephalic term pregnancies Obstet Gynecol 105 2005 537 542
41. M.I. Cedergren Maternal morbid obesity and the risk of adverse pregnancy outcome Obstet Gynecol 103 2004 219 224
42. P.D. Wall, E.E. Deucy, J.C. Glantz, and E.K. Pressman Vertical skin incisions and wound complications in the obese parturient Obstet Gynecol 102 2003 952 956
43. T.D. Myles, J. Gooch, and J. Santolaya Obesity as an independent risk factor for infectious morbidity in patients who undergo cesarean delivery Obstet Gynecol 100 2002 959 964
44. R. Corosu, F. Vizzaccaro, and S. Moretti Incidence of thromboembolic complications in cesarean sections and heparin prophylaxis Minerva Ginecol 51 1999 173 176
45. K.M. McTigue, R. Harris, and B. Hemphill Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 139 2003 933 949
46. K.P. Jones, and R.A. Wild Contraception for patients with psychiatric or medical disorders Am J Obstet Gynecol 170 1994 1575 1580
47. H. Fu, J.E. Darroch, T. Haas, and N. Ranjit Contraceptive failure rates: new estimates from the 1995 National Survey of Family Growth Fam Plann Perspect 31 1999 56 63
48. P.D. Connor, L.A. Tavernier, S.M. Thomas, D. Gates, and S.M. Lytton Determining risk between Depo-Provera use and increased uterine bleeding in obese and overweight women J Am Board Fam Pract 15 2002 7 10
49. H.B. Croxatto Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant Eur J Contracept Reprod Health Care 5 Suppl. 2 2000 21 28
50. D. Hubacher, and D.A. Grimes Noncontraceptive health benefits of intrauterine devices: a systematic review Obstet Gynecol Surv 57 2002 120 128
51. L. Bahamondes, P. Ribeiro-Huguet, K.C. de Andrade, O. Leon-Martins, and C.A. Petta Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma Acta Obstet Gynecol Scand 82 2003 580 582